• Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%

    المصدر: Buzz FX / 20 يناير 2025 06:20:23   America/New_York


    Indian pharmaceutical (IT) major,
    Dr Reddy’s Laboratories, is scheduled to deliver itsOctober-December quarterly earningsfor the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025. According to analyst estimates compiled by Busin
    Read more...
شارك على،